Ticker LaunchCanada to US · Cross-listing · CRDL
Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. (CRDL), a Ontario-based company, cross-listed on Nasdaq on Aug 4, 2021, registering its securities on Form 8-A12B.
Cardiol Therapeutics Inc. is a clinical-stage life sciences company developing cannabidiol as an anti-fibrotic and anti-inflammatory therapy for cardiovascular disease. Its lead product candidate is CardiolRx, a pharmaceutically produced oral cannabidiol formulation.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- CRDL
- Listed
- Aug 4, 2021
- Province
- Ontario
- Registration form
- 8-A12B
- Security
- Common shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (8-A12B) Aug 4, 2021
- Offering document
- All filings on EDGAR CIK 1702123
Other Canadian companies listing in the US
- Nomad Royalty Company Ltd.NYSE · Aug 30, 2021
- Bragg Gaming Group Inc.Nasdaq · Aug 25, 2021
- VIQ Solutions Inc.Nasdaq · Aug 6, 2021
- Draganfly Inc.Nasdaq · Jul 28, 2021
- Cybin Inc.NYSE American · Jul 26, 2021
- Field Trip Health Ltd. (now Reunion Neuroscience Inc.)Nasdaq · Jul 19, 2021